American Cancer Society perspectives on environmental factors and cancer

CA Cancer Journal for Clinicians

Volumn 59, Issue 6, 2009, Pages 343-351

  Fontham, Elizabeth T H ^a   Thun, Michael J ^b   Ward, Elizabeth ^b   Balch, Alan J ^b   Delancey, John Oliver L ^b   Samet, Jonathan M ^c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARCINOGEN; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; WART VIRUS VACCINE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENICITY; CHEMICAL INDUSTRY; DNA DAMAGE; ENVIRONMENTAL FACTOR; HUMAN; LEUKEMIA; LUNG CANCER; MEDICAL RESEARCH; MEDICAL SOCIETY; MESOTHELIOMA; NEOPLASM; NONHUMAN; POLLUTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

AMERICAN CANCER SOCIETY; ANIMALS; BIOMEDICAL RESEARCH; CARCINOGENS; COST OF ILLNESS; ENVIRONMENTAL POLLUTANTS; HUMANS; NEOPLASMS; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION; UNITED STATES;

EID: 72749117649     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.20041     Document Type: Review

References (51)

1. Wipfli H, Samet JM. Global economic and health benefits of tobacco control: part 1. Clin Pharmacol Ther. 2009;86:263-271.
2. Wipfli H, Samet JM. Global economic and health benefits of tobacco control: part 2. Clin Pharmacol Ther. 2009;86:272-280.
3. Cokkinides V, Bandi P, McMahon C, et al. Tobacco control in the United States - recent progress and opportunities. CA Cancer J Clin. 2009;59:000-000
4. Calle EE, Rodriquez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-1638. (Pubitemid 36459468)
5. Kushi LH, Byers T, Doyle C, et al; American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006;56:254-281; quiz 313-314.
6. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27-41.
7. Ward EM, Schulte PA, Bayard S, et al; National Occupation Research Agenda Team. Priorities for development of research methods in occupational cancer. Environ Health Perspect. 2003;111:1-12.
8. Rheingold S, Neugat A, Meadows A. Treatment- related secondary cancers. In: Holland JF, ed. Cancer Medicine 7. Hamilton, Ontario, Canada: BC Dekker; 2006:2216-2221.
9. Inskip P. Second cancers following radiotherapy in Multiple Primary Cancers. In: Neugat A, Meadows RE, eds. Title. Philadelphia: Lippincott Williams & Wilkins; 1999: 91-136.
10. Fung VA, Barrett JC, Huff J. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. Environ Health Perspect. 1995;103:680-683.
11. Ecobichon DJ. Mutagenesis-carcinogenesis. In: Ecobichon DJ, ed. The Basis of Toxicology Testing. Montreal, Quebec, Canada: CRC Press; 1997:157-190.
12. Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC: National Research Council of the National Academies; 2007.
13. Towards 2020: Making Chemicals Safer: The EU's Contribution to the Strategic Approach to International Chemicals Management. Available at: http://ec.europa. eu/environment/chemicals/reach/ pdf/SAICM-09%20-en.pdf. Accessed 9 August 2009.
14. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer, World Health Organization; 2006.
15. National Toxicology Program. Report on Carcinogens. 11th ed. Washington, DC: US Department of Health and Human Services, Public Health Service, National Toxicology Program; 2005.
16. Budzowska M Kanaar R. Mechanisms of dealing with DNA damage-induced replication problems. Cell Biochem Biophys. 2009; 53:17-31.
17. Zeise L, Cardis E, Hemminki K, Schuarz M. Quantitative estimation and prediction of cancer risk: review of existing activities. In: Moolgavkar S, et al, eds. Quantitative Estimation and Prediction of Human Cancer Risks. Lyon, France: International Agency for Research on Cancer; 1999:11-59.
18. Doll R Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191-1308.
19. Steenland K, Burnett C, Lalich N, Ward E, Hurrell J. Dying for work: the magnitude of US mortality from selected causes of death associated with occupation. Am J Ind Med. 2003;43:461-482. (Pubitemid 36537766)
20. Rushton L, Hutchings S, Brown T. The burden of cancer at work: estimation as the first step to prevention. Occup Environ Med. 2008;65:789-800.
21. Driscoll T, Takala J, Steenland K, Corvalan C, Fingerhut M. Review of estimates of the global burden of injury and illness due to occupational exposures. Am J Ind Med. 2005;48:491-502. (Pubitemid 41746866)
22. Darby S, Hill D, Deot I, et al. Residential radon and lung cancer-detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health. 2006;32(suppl 1):1-83.
23. Vineis P, Hoek G, Krzyzanowski M, et al. Lung cancers attributable to environmental tobacco smoke and air pollution in nonsmokers in different European countries: a prospective study. Environ Health. 2007;6:7.
24. Straif K, Bann R, Grosse Y, et al. WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of household solid fuel combustion and of high-temperature frying. Lancet Oncol. 2006;7:977-978.
25. American Cancer Society. Cancer Facts & Figures 2007. Atlanta: American Cancer Society;2007:42-43.
26. Fontham ET. Infectious diseases and global cancer control. CA Cancer J Clin. 2009; 59:5-7.
27. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis. 2003;7: 67-86. (Pubitemid 36469352)
28. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57:7-28. (Pubitemid 46148088)
29. American Cancer Society. Cancer Facts & Figures 2005. Atlanta: American Cancer Society;2005:22-35.
30. Hill AB. The environment and disease: association or causation. Proc R Soc Med. 1965;58:295-300.
31. Shields PG. Understanding population and individual risk assessment: the case of polychlorinated biphenyls. Cancer Epidemiol Biomarkers Prev. 2006;15:830-839.
32. Selikoff I, Churg J, Hammond E. Asbestos exposure and neoplasia. JAMA. 1964;188: 22-26.
33. Selikoff I, Hammond E, Churg J. Asbestos exposure, smoking and neoplasia. JAMA. 1968;204:106-112.
34. Selikoff I, Churg J, Hammond E. Relation between exposure to asbestos and mesothelioma. N Engl J Med. 1965;272:560-565.
35. Steenland K, Henley J, Thun M. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am J Epidemiol. 2002;156: 11-21.
36. Steenland K, Henley J, Calle E, Thun M. Individual- and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons. Am J Epidemiol. 2004;159:1047-1056.
37. Pope CA 3rd, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of US. adults.AmJ Respir Crit Care Med. 1995;151: 669-674.
38. Pope CA 3rd, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132-1141.
39. Pope CA 3rd, Burnett RT, Thurston GD, et al. Cardiovascular mortality and long-term exposure to particulate air pollution. Circulation. 2004;109:71-77.
40. Jerrett M, Burnett RT, Ma R, et al. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology. 2005;16:727-736. (Pubitemid 41681538)
41. Jerrett M, Burnett RT, Pope CA 3rd, et al. Long-term ozone exposure and mortality. N Engl J Med. 2009;360:1085-1095.
42. Steenland K. Passive smoking and the risk of heart disease. JAMA. 1992;267:94-99.
43. Cardenas VM, Thun MJ, Austin H, et al. Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's Cancer Prevention Study II. Cancer Causes Control. 1997;8:57-64. (Pubitemid 27092942)
44. Thun MJ, Altekruse SF, Namboodiri MM, et al. Hair dye use and risk of fatal cancers in U.S. women. J Natl Cancer Inst. 1994;86: 210-215.
45. Altekruse SF, Henley SJ, Thun MJ. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control. 1999;10:617-625.
46. American Cancer Society. Cancer Facts & Figures 2006. Atlanta: American Cancer Society;2006:22-31.
47. Ward EM, Thun MJ, Hannan LM, Jemal A. Interpreting cancer trends. Ann N Y Acad Sci. 2006;1076:29-53.
48. Jones LC, Whitlock JP Jr. Dioxin-inducible transactivation in a chromosomal setting. Analysis of the acidic domain of the Ah receptor. J BiolChem. 2001;276:25037-25042. (Pubitemid 37412980)
49. Johnson MD, Kenney M, Stoica A, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med. 2003;9:1081-1084. (Pubitemid 37021790)
50. Moore LE, Pfeiffer R, Warner M, et al. Identification of biomarkers of arsenic exposure and metabolism in urine using SELDI technology. J Biochem Mol Toxicol. 2005; 19:176. (Pubitemid 40967288)
51. Perlow RA, Broyde S. Extending the understanding of mutagenicity: structural insights into primer-extension past a benzo- [a]pyrene diol epoxide-DNA adduct. J Mol Biol. 2003;327:797-818. (Pubitemid 36315920)